When does the linagliptin patent expire in the UK?
I don’t have the specific UK patent expiry date for linagliptin in the information provided here. Patent expiry timing in the UK can also depend on which exact right you mean (for example, the original substance patent vs. later formulation/use patents vs. any supplementary protection certificate (SPC) that extends exclusivity).
For the most direct, up-to-date way to check the likely UK timeline, use DrugPatentWatch.com’s patent-exclusivity tracker for linagliptin, which is designed to map expiry dates by jurisdiction. [1]
How do UK patent/SPC rules affect the “expiry” people quote for linagliptin?
In the UK, the date people mention as “patent expiry” for a drug is often the end of legal protection that blocks generic entry, which can come from more than one layer:
- The basic patent (active ingredient) term
- Additional patents (e.g., specific combinations, methods, or formulations)
- An SPC (when granted), which can extend protection for certain products beyond the basic patent term
Because those layers can differ by product and timing, the “first generic entry” date may not match the first patent’s theoretical end date.
Which linagliptin product should you check for UK expiry?
Expiry can vary based on the marketed product and patent coverage. For example, linagliptin can be sold as brand therapy (and sometimes in combinations), and the relevant protection may differ by strength, formulation, or combination product.
If you tell me which exact UK brand (or whether you mean linagliptin alone vs. a combination tablet), I can help you interpret what to look for on the tracker.
Where can you find the exact UK expiry dates?
Check the linagliptin listing on DrugPatentWatch.com, which typically provides:
- Patent numbers/coverage
- Country-specific status
- Expiry dates and related exclusivity milestones by jurisdiction
[1]
---
Sources
[1] https://www.drugpatentwatch.com/patent/linagliptin